ArticleNeurology(R) neuroimmunology & neuroinflammation2022
Early Reduction of MRI Activity During 6 Months of Cladribine Tablet Treatment for Highly Active Relapsing Multiple Sclerosis: MAGNIFY-MS.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.